State of the Science on Brain Insulin Resistance and Cognitive Decline Due to Alzheimer’s Disease DOI Creative Commons
Elizabeth M. Rhea,

Manon Leclerc,

Hussein N. Yassine

et al.

Aging and Disease, Journal Year: 2023, Volume and Issue: unknown, P. 0 - 0

Published: Jan. 1, 2023

Type 2 diabetes mellitus (T2DM) is common and increasing in prevalence worldwide, with devastating public health consequences. While peripheral insulin resistance a key feature of most forms T2DM has been investigated for over century, research on brain (BIR) more recently developed, including the context non-diabetes states. Recent data support presence BIR aging brain, even states, found that may be Alzheimer’s disease (AD) contributes to cognitive impairment. Further, therapies used treat are now being AD treatment prevention, insulin. In this review, we offer definition BIR, present evidence AD; discuss expression, function, activation receptor (INSR) brain; how could develop; tools study BIR; correlates current hallmarks; regional/cellular involvement BIR. We close discussion resilience both AD, can improved better understand future avenues research. Overall, review position paper highlights as plausible therapeutic target prevention decline dementia due AD.

Language: Английский

Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches DOI

Derek Kellar,

Suzanne Craft

The Lancet Neurology, Journal Year: 2020, Volume and Issue: 19(9), P. 758 - 766

Published: July 27, 2020

Language: Английский

Citations

597

Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression DOI
Thomas T. van Sloten, Sanaz Sedaghat, Mercedes R. Carnethon

et al.

The Lancet Diabetes & Endocrinology, Journal Year: 2020, Volume and Issue: 8(4), P. 325 - 336

Published: March 2, 2020

Language: Английский

Citations

481

Emerging Targets in Type 2 Diabetes and Diabetic Complications DOI Creative Commons
Sevgican Demir, Peter P. Nawroth, Stephan Herzig

et al.

Advanced Science, Journal Year: 2021, Volume and Issue: 8(18)

Published: July 28, 2021

Abstract Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although large drug portfolio exists to keep the levels under control, these medications are not without side effects. More importantly, once diagnosed rarely reversible. Dysfunctions in kidney, retina, cardiovascular system, neurons, liver represent common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, molecular mechanisms how type develops leads irreparable damage remain elusive. This review particularly focuses on novel targets may play role pathogenesis diabetes. Further research eventually pave way for treatment—or even prevention—of along with its complications.

Language: Английский

Citations

325

Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? DOI Creative Commons
Maria Vallet‐Regí, Ferdi Schüth, Daniel Lozano

et al.

Chemical Society Reviews, Journal Year: 2022, Volume and Issue: 51(13), P. 5365 - 5451

Published: Jan. 1, 2022

The present review details a chronological description of the events that took place during development mesoporous materials, their different synthetic routes and use as drug delivery systems. outstanding textural properties these materials quickly inspired translation to nanoscale dimension leading silica nanoparticles (MSNs). aspects introducing pharmaceutical agents into pores nanocarriers, together with possible biodistribution clearance routes, would be described here. smart nanocarriers are able release high local concentration therapeutic cargo on-demand after application certain stimuli reviewed here, ability deliver precise locations in body. huge progress design MSNs for biomedical applications, including potential treatment diseases, last 20 years will collated required work still needs done achieve clinical materials. This was conceived stand out from past reports since it aims tell story systems by some makers, who could considered among pioneers this area.

Language: Английский

Citations

279

Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases DOI Open Access
Maria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono

et al.

Nutrients, Journal Year: 2020, Volume and Issue: 12(4), P. 1066 - 1066

Published: April 12, 2020

Insulin resistance (IR), defined as an attenuated biological response to circulating insulin, is a fundamental defect in obesity and type 2 diabetes (T2D), also linked wide spectrum of pathological conditions, such non-alcoholic fatty liver disease (NAFLD), cognitive impairment, endothelial dysfunction, chronic kidney (CKD), polycystic ovary syndrome (PCOS), some endocrine tumors, including breast cancer. In obesity, the unbalanced production pro- anti-inflammatory adipocytokines can lead development IR its related metabolic complications, which are potentially reversible through weight-loss programs. The Mediterranean diet (MedDiet), characterized by high consumption extra-virgin olive oil (EVOO), nuts, red wine, vegetables other polyphenol-rich elements, has proved be associated with greater improvement obese individuals, when compared nutritional interventions. Also, recent studies either experimental animal models or humans, have shown encouraging results for insulin-sensitizing supplements derived from MedDiet food sources modulation pathognomonic traits certain IR-related polyunsaturated acids seeds, anthocyanins purple fruits, resveratrol grapes, EVOO-derived, oleacein. Although pharmacological properties clinical uses these functional nutrients still under investigation, molecular mechanism(s) underlying benefits appear compound-specific and, cases, point role gene expression involvement nuclear high-mobility group A1 (HMGA1) protein.

Language: Английский

Citations

212

Solving neurodegeneration: common mechanisms and strategies for new treatments DOI Creative Commons
Lauren K. Wareham, Shane A. Liddelow, Sally Temple

et al.

Molecular Neurodegeneration, Journal Year: 2022, Volume and Issue: 17(1)

Published: March 21, 2022

Across neurodegenerative diseases, common mechanisms may reveal novel therapeutic targets based on neuronal protection, repair, or regeneration, independent of etiology site disease pathology. To address these and discuss emerging treatments, in April, 2021, Glaucoma Research Foundation, BrightFocus the Melza M. Frank Theodore Barr Foundation collaborated to bring together key opinion leaders experts field for a virtual meeting titled "Solving Neurodegeneration". This "think-tank" style focused uncovering mechanistic roots promising new catalyzed by goal finding treatments glaucoma, world's leading cause irreversible blindness interest three hosting foundations. Glaucoma, which causes vision loss through degeneration optic nerve, likely shares early cellular molecular events with other diseases central nervous system. Here we major areas overlap between system: neuroinflammation, bioenergetics metabolism, genetic contributions, neurovascular interactions. We summarize important discussion points emphasis research that are most innovative treatment neurodegeneration yet require further development. The is highlighted provides unique opportunities collaboration will lead efforts preventing ultimately loss.

Language: Английский

Citations

193

Central nervous pathways of insulin action in the control of metabolism and food intake DOI
Stephanie Kullmann, André Kleinridders, Dana M. Small

et al.

The Lancet Diabetes & Endocrinology, Journal Year: 2020, Volume and Issue: 8(6), P. 524 - 534

Published: May 21, 2020

Language: Английский

Citations

175

Inflammation From Peripheral Organs to the Brain: How Does Systemic Inflammation Cause Neuroinflammation? DOI Creative Commons
Yuanjie Sun, Yoshihisa Koyama, Shoichi Shimada

et al.

Frontiers in Aging Neuroscience, Journal Year: 2022, Volume and Issue: 14

Published: June 16, 2022

As inflammation in the brain contributes to several neurological and psychiatric diseases, cause of neuroinflammation is being widely studied. The causes can be roughly divided into following domains: viral infection, autoimmune disease, from peripheral organs, mental stress, metabolic disorders, lifestyle. In particular, effects caused by organs have yet unclear mechanisms. Many such as gastrointestinal inflammation, chronic obstructive pulmonary rheumatoid arthritis, dermatitis, fatigue syndrome, or myalgic encephalomyelitis (CFS/ME), trigger through pathways. mechanisms action for inflammation-induced include disruption blood-brain barrier, activation glial cells associated with systemic immune activation, on autonomic nerves via organ-brain axis. this review, we consider previous studies relationship between neuroinflammation, focusing regions susceptible inflammation.

Language: Английский

Citations

154

The brain as an insulin-sensitive metabolic organ DOI Creative Commons
Joshua L. Milstein, Heather A. Ferris

Molecular Metabolism, Journal Year: 2021, Volume and Issue: 52, P. 101234 - 101234

Published: April 16, 2021

The brain was once thought of as an insulin-insensitive organ. We now know that the insulin receptor is present throughout and serves important functions in whole-body metabolism function. Brain signaling involved not only homeostatic processes but also neuropathological such cognitive decline Alzheimer's disease.

Language: Английский

Citations

147

Insulin action in the brain: cell types, circuits, and diseases DOI Creative Commons
Wenqiang Chen, Weikang Cai, Benjamin Hoover

et al.

Trends in Neurosciences, Journal Year: 2022, Volume and Issue: 45(5), P. 384 - 400

Published: March 28, 2022

Language: Английский

Citations

93